中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Pre-medication With Alfentanil vs Placebo During ECT

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Wake Forest University Health Sciences

关键词

抽象

Hemodynamic changes associated with the conduct of electroconvulsive therapy may be minimized with the administration of alfentanil as part of their anesthetic regimen. This study proposes to compare the effects in a blinded fashion. Currently alfentanil is an FDA approved drug used on a daily basis by anesthesiologists on other surgeries so this is not a new indication.

描述

Electroconvulsive therapy is associated with brief hemodynamic alterations that in some patients may be well outside the range of normalcy and potentially dangerous to the patient (Duma A, et al). This cardiovascular response is caused by activation of the autonomic nervous system and consists of an initial parasympathetic response rapidly followed by sympathetically mediated tachycardia and hypertension. The ultra-short acting synthetic opioid alfentanil has a rapid onset and duration of action that mirrors the duration of hemodynamic perturbation associated with ECT while having minimal or no effect on the duration or quality of the seizure. This drug may be effective in blunting the hemodynamic perturbations associated with ECT with a minimal amount of side effects.

日期

最后验证: 01/31/2020
首次提交: 11/26/2017
提交的预估入学人数: 11/26/2017
首次发布: 12/01/2017
上次提交的更新: 05/07/2020
最近更新发布: 05/11/2020
实际学习开始日期: 06/03/2018
预计主要完成日期: 02/16/2020
预计完成日期: 02/16/2020

状况或疾病

Blood Pressure
Electroconvulsive Therapy

干预/治疗

Drug: Alfentanil

Drug: placebo

相 4

手臂组

干预/治疗
Active Comparator: Alfentanil
Drug: Alfentanil
Administration of alfentanil during the induction and maintenance of anesthesia for electroconvulsive therapy to be performed
Placebo Comparator: placebo
Drug: placebo
Administration of a equidose placebo during the induction and maintenance of anesthesia for electroconvulsive therapy to be performed

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Age > /=18 years

- Males or females

- Anticipating electroconvulsive therapy to treat refractory depressive disorder

Exclusion Criteria:

- Under the age of 18

- Allergy to alfentanil

- Allergy to other standard anesthetic medications utilized in the course of ECT (glycopyrrolate, methohexital, and succinylcholine)

- History of malignant hyperthermia

- History of severe airway obstruction, bronchospasm or laryngospasm

- History of recent myocardial infarction, ventricular arrhythmia

- Adverse reaction to ECT requiring premedication with lidocaine or atropine

- Non-English speaking

- Patients unable to consent for themselves

- Current pregnancy

结果

主要结果指标

1. Systolic blood pressure change [90 minutes]

comparision of Systolic blood pressure changes alfentanil vs placebo

2. Diastolic blood pressure change [90 minutes]

comparison of diastolic blood pressure change alfentanil vs placebo

3. Heart rate [90 minutes]

comparison of heart rate change alfentanil vs placebo

4. Antihypertensive medication use [90 minutes]

comparison of amounts of medications needed to treat blood pressure between the 2 groups

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge